High accumulation of linezolid and its major metabolite in the serum of patients with hepatic and renal dysfunction is significantly associated with thrombocytopenia and anemia

利奈唑啉 医学 肾功能 贫血 内科学 胃肠病学 不利影响 药品 肝功能 治疗药物监测 接收机工作特性 静脉血 药理学 生物 万古霉素 细菌 遗传学 金黄色葡萄球菌
作者
Junqiang Gou,Qian Li,Ning Fan,Chen Zhang,Haïwen Tang,Xiaofeng Wang,Dongfeng Yin
出处
期刊:Microbiology spectrum [American Society for Microbiology]
卷期号:13 (7): e0249324-e0249324 被引量:8
标识
DOI:10.1128/spectrum.02493-24
摘要

This study aims to examine the serum levels of linezolid and its metabolites (PNU-142300 and PNU-142586) in patients with varying hepatic and renal function. It seeks to understand how these levels relate to thrombocytopenia and anemia and to identify concentration thresholds that could cause these adverse effects, thereby aiding in personalized drug dosing. This prospective study was conducted from January to December 2023. According to the established inclusion and exclusion criteria, 77 patients with infections treated with linezolid were selected as the research subjects. Venous blood samples were collected every 48 h starting from the first use of linezolid, specifically 30 min before the next dose. Laboratory data were obtained through biochemical analysis and blood routine tests, and blood drug concentration monitoring was carried out based on the pre-established high-performance liquid chromatography (HPLC) method. The exposure levels of linezolid and its metabolites in the serum of patients under different liver and kidney function states were compared, and the relationships between these drug exposure levels and platelet count and hemoglobin concentration were analyzed. Additionally, the receiver operating characteristic (ROC) curve was used to determine the blood drug concentration thresholds of linezolid and its metabolites that led to thrombocytopenia or anemia. Finally, survival analysis was used to evaluate the time differences in the occurrence of adverse reactions, such as thrombocytopenia and anemia, between the liver and kidney function impairment group and the normal group after the use of linezolid. Exposure to linezolid and its metabolites increased with the severity of hepatic and renal impairment. Patients with severe and moderate hepatic and renal impairment had a substantially higher median C min of linezolid and its metabolites 2 and 3 than those with mild hepatic and renal impairment. The platelet count and hemoglobin concentration were significantly associated with linezolid and its metabolite overexposure. The concentration threshold for linezolid and its metabolites 2 and 3 to cause thrombocytopenia and anemia were 7.0, 3.6, and 4.3 mg/L. Patients with hepatic and renal impairment exhibit higher levels of linezolid and its metabolites, potentially leading to adverse effects like thrombocytopenia and anemia. It is recommended to monitor drug levels and develop individualized dosage regimens. IMPORTANCE The accumulation of plasma linezolid and its metabolites increased with the degree of liver and kidney injury. High plasma linezolid and its metabolite accumulation is significantly associated with thrombocytopenia and anemia. Linezolid and its metabolite concentration threshold can warn the clinical prevention of hematological adverse reactions. Individual therapy guided by therapeutic drug monitoring (TDM) can improve the efficacy of linezolid and reduce toxic reactions. Patients with severe hepatic and renal dysfunction should actively monitor the blood routine and linezolid concentration and adjust the dosage in time.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
霸气的思柔完成签到,获得积分10
1秒前
Nihai完成签到 ,获得积分10
2秒前
2秒前
情怀的应助被18756828852采纳,获得10
3秒前
Echo完成签到 ,获得积分10
3秒前
3秒前
SUN发布了新的文献求助10
3秒前
4秒前
GG酱发布了新的文献求助10
4秒前
ZP完成签到,获得积分20
4秒前
等待广缘发布了新的文献求助10
4秒前
佘炭炭发布了新的文献求助10
4秒前
5秒前
6秒前
fxl666完成签到,获得积分10
6秒前
ZP发布了新的文献求助10
7秒前
7秒前
Kyra发布了新的文献求助10
8秒前
lh完成签到 ,获得积分10
8秒前
Jasper的应助被ccccelia采纳,获得10
8秒前
大模型的应助被xingzhou采纳,获得10
9秒前
斯文败类的应助被高贵乌冬面采纳,获得10
10秒前
JamesPei的应助被GG酱采纳,获得30
11秒前
Sia完成签到,获得积分10
11秒前
11秒前
LL完成签到,获得积分10
11秒前
12秒前
香芋发布了新的文献求助10
12秒前
炙热之霜完成签到,获得积分10
13秒前
13秒前
syvshc的应助被候佳祥采纳,获得10
14秒前
科研通AI65的应助被njebcuiebvjc采纳,获得10
14秒前
lh关注了科研通微信公众号
15秒前
洋芋大侠发布了新的文献求助10
16秒前
Zard完成签到,获得积分10
16秒前
ding的应助被seven采纳,获得10
19秒前
19秒前
刘莉莉完成签到,获得积分10
19秒前
飞飞完成签到,获得积分10
21秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192841
求助须知:如何正确求助?哪些是违规求助? 9579236
关于积分的说明 21864289
捐赠科研通 7792410
什么是DOI,文献DOI怎么找? 3437059
关于科研通互助平台的介绍 2560639
邀请新用户注册赠送积分活动 2483927